Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 9/20 | 0.34 |
| ▸ | MMP3 | P08254 | 5/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25139599 | 1.00 | HPGD (0.38) | HPGDMMP2MMP3POLBALDH1A1 | |
| SCHEMBL29178461 | 1.00 | HPGD (0.38) | HPGDMMP2MMP3POLBALDH1A1 | |
| SCHEMBL29178321 | 0.88 | HPGD (0.37) | HPGDMMP2MMP3ALDH1A1GAA | |
| SCHEMBL24814271 | 0.88 | HPGD (0.37) | HPGDMMP2MMP3ALDH1A1GAA | |
| SCHEMBL29178318 | 0.88 | HPGD (0.37) | HPGDMMP2MMP3ALDH1A1GAA | |
| SCHEMBL29178383 | 0.82 | FAAH (0.36) | HPGDMMP2MMP3 | |
| SCHEMBL24814186 | 0.82 | FAAH (0.36) | HPGDMMP2MMP3 | |
| SCHEMBL29178388 | 0.82 | FAAH (0.36) | HPGDMMP2MMP3 | |
| SCHEMBL18432169 | 0.76 | — | — | |
| SCHEMBL19841795 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4358954-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117561058-A | CDK2 inhibitors and methods of use thereof | 塞迪拉治疗股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| WO-2022272106-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2022-12-29 | — | — | WO | disclosed |